Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 14, 2010 08:00 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at the 2010 Deutsche Bank BioFEST Conference

CHARLOTTE, N.C., Dec. 14, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) will webcast its session at the 2010 Deutsche Bank BioFEST at 11:30 a.m. ET on Tuesday,...
November 01, 2010 16:05 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Reports Third Quarter 2010 Results

CHARLOTTE, N.C., Nov. 1, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) reported financial results for the third quarter 2010 and presented a quarterly update on the...
October 29, 2010 07:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at the Oppenheimer 21st Annual Healthcare Conference

CHARLOTTE, N.C., Oct. 29, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the Oppenheimer 21st Annual Healthcare Conference at 1:35 PM on...
October 27, 2010 07:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Host Conference Call to Discuss Third Quarter 2010 Results

CHARLOTTE, N.C., Oct. 27, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it will release third quarter results for the period ended Sept 30, 2010 after...
October 19, 2010 07:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at 2010 Newsmakers in the Biotechnology Industry Conference

CHARLOTTE, N.C., Oct. 19, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 2010 Newsmakers in the Biotechnology Industry Conference at...
October 06, 2010 11:27 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Completes Public Offering of Common Stock

CHARLOTTE, N.C., Oct. 6, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) has completed its previously announced public offering of common stock and announced that the...
October 01, 2010 08:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Prices Public Offering of Common Stock

CHARLOTTE, N.C., Oct. 1, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced today that it has priced a public offering of approximately 7.14 million shares of...
September 28, 2010 16:00 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Announces Public Offering of Common Stock

CHARLOTTE, N.C., Sept. 28, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced today its intention, subject to market and other conditions, to offer $35 million...
September 27, 2010 07:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Initiates CH-4051 Phase II Trial in Rheumatoid Arthritis

CHARLOTTE, N.C., Sept. 27, 2010 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) has initiated enrollment in a multinational, 12-week, double-blind Phase II trial designed to...
September 20, 2010 06:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Reports Phase III Trial of Northera Met Primary Endpoint and Achieved Highly Significant Symptomatic Benefits in Neurogenic Orthostatic Hypotension

Northera Provided Statistically Significant Improvement Over Placebo on Composite Orthostatic Questionnaire Score (p=0.003) Study Showed Statistically Significant Benefits in all 3 Composite...